Incorporating AI into Commercialization Plans

As a result, the provider increases its involvement in the country’s pharma sector.

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.

The value of this sometimes-unheralded technology to the pharma industry—as well as potential use cases—are starting to come to light.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Filling the gaps in the patient journey within an increasingly complex data environment.